The U.S. Army awarded Palantir a 10-year contract with a $10 billion ceiling value, which consolidates 75 existing contracts into a streamlined procurement vehicle. In addition, the Trump ...

Investing.com -- Shares of U Blox Holding AG (SIX:UBXN) fell 3.3% on Monday after private equity group Advent International announced plans to buy the Swiss semiconductor company in a cash offer ...

Gold futures are trading at $3,381.7, holding steady within a razor-thin band ($3,375–$3,385) after declining from the August 7 high a ...

FRANKFURT (Reuters) -Home building permits in Germany rose 7.9% in June from a year earlier, statistics office data showed on Monday, as the nation’s troubled property industry continues to find its ...

Investors now rely on an ever-expanding Bubble Term that was driven by ‘free money’ monetary and fiscal policies that will not only have to persist – but will have to expand without limit in order to ...

COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug ...

The move from the April 21 low is in a tight bull channel, indicating strong bullish momentum. The buying pressure remains stronger (consecutive bull bars) compared to the weaker selling pressure ...

S&P 500, Microsoft Corporation, Alphabet Inc Class A, NVIDIA Corporation. Read 's Market Analysis on Investing.com ...

Investing.com -- China will extend its investigation into dairy imports from the European Union for an additional six months, pushing the decision deadline to Feb. 21, 2026. The Chinese commerce ...

Investing.com -- Spain’s public debt decreased to 103.4% of gross domestic product (GDP) at the end of June, according to data released by the Bank of Spain on Monday. This marks a reduction from the ...

Wegovy becomes the first GLP-1 based therapy authorized for MASH, which affects roughly 5% of U.S. adults, according to the American Liver Foundation. Until now, the only FDA-approved treatment for ...

Investing.com -- U.S. software stocks may see short-term gains in the current earnings cycle, even as questions over ...